AXT, Inc. is a worldwide materials science company that develops and produces high performance compound and single element semiconductor substrates, also known as wafers. The company’s products serve applications where conventional silicon substrates cannot meet performance requirements, such as in high speed data transfer, optoelectronics, and specialized solar cells.
AXT generates revenue primarily from the sale of its substrate wafers and related raw materials. In…
AXT, Inc. is a worldwide materials science company that develops and produces high performance compound and single element semiconductor substrates, also known as wafers. The company’s products serve applications where conventional silicon substrates cannot meet performance requirements, such as in high speed data transfer, optoelectronics, and specialized solar cells.
AXT generates revenue primarily from the sale of its substrate wafers and related raw materials. In 2025, substrate products accounted for approximately 67% of consolidated revenue while raw materials contributed the remaining 33%; comparable splits were 68%/32% in 2024 and 63%/37% in 2023. The wafers are sold to manufacturers that apply epitaxial layers, and the raw materials are sold both for internal use and to third party customers.
The company operates through the following segments.
• Substrate product group: This segment designs, manufactures and sells semiconductor wafers made from indium phosphide (InP), gallium arsenide (GaAs) and germanium (Ge). These wafers enable high speed optical communication, 5G infrastructure, fiber optics, light emitting diodes, laser devices and solar cell applications.
• Raw materials product group: This segment produces and sells critical inputs for wafer fabrication, including pyrolytic boron nitride crucibles, purified gallium, indium phosphide base material, arsenic, gallium magnesium alloy and boron oxide. These materials are used internally and also marketed to other companies for their own semiconductor and optoelectronic processes.
Within the specialty semiconductor substrate market, AXT competes with established firms such as Sumitomo Electric Industries, Japan Energy (JX), Freiberger Compound Materials, Umicore, China Crystal Technology Corp., and Vital Materials. The company differentiates itself through its claim of best in class indium phosphide wafers with low defect densities, its capability to produce low etch pit density gallium arsenide wafers up to eight inches, and its vertically integrated supply chain that provides control over key raw materials. AXT also highlights its access to both U. S. and Chinese capital markets and its low cost manufacturing base in China as competitive advantages.
AXT serves semiconductor and optoelectronic device manufacturers that require epitaxial layer application, as well as research institutions and universities experimenting with III and V and germanium materials. Its customers are located primarily in Asia, Europe and the United States, with no single customer accounting for more than ten percent of revenue in recent years.
Sectors:Technology · Basic MaterialsSector rationaleThe primary business is the design and manufacture of semiconductor substrates (wafers) made from InP, GaAs, and Ge, which falls under Semiconductor Materials in the Technology sector. A secondary sector is justified because the company also operates a substantial 'Raw materials product group' that produces and sells purified gallium, arsenic, and boron oxide to third parties, which are intermediate materials sold to other manufacturers.Industries:Semiconductor MaterialsTechnologyPrimaryAXT produces and sells semiconductor substrates (wafers) made from indium phosphide, gallium arsenide, and germanium, which are consumables consumed in the chip fabrication process. These products, along with the company's raw materials, are sold to manufacturers that apply epitaxial layers to create finished semiconductors.Specialty ChemicalsBasic MaterialsSecondaryThe company sells high-performance compound materials and critical inputs such as purified gallium, indium phosphide base material, and gallium magnesium alloy to third-party customers for use in their own semiconductor and optoelectronic processes.Classified using BQ-MICSCIK: 0001051627
Investment Thesis
▲ Bull case
AXT, Inc. is positioned to capitalize on a structural shift in the indium phosphide (InP) substrate market driven by accelerating AI infrastructure investment and the emergence of co-packaged optics (CPO), with management signaling that the substrate market could grow four to six times over the next three to five years, far exceeding near-term cyclical fluctuations and creating a multi-year demand tailwind that remains underappreciated by the market; this is reinforced by the company’s record backlog exceeding $100 million, which reflects not just transient demand but deeper customer visibility and long-term supply agreement discussions with tier-one laser manufacturers, optical transceiver makers, and even hyperscalers’ end customers, indicating a broadening and deepening of the customer base beyond traditional clients.
The company’s unique integrated supply chain strategy—including ownership of crystal growth furnaces, control over critical raw materials through subsidiaries like Jinmei refining high-purity indium, and in-house crucible production via BoYu—provides a durable competitive moat that is difficult for peers to replicate, especially as raw material constraints and export permitting complexities intensify; this vertical integration allows AXT to maintain margin stability and supply reliability during periods of geopolitical stress, a factor highlighted when Morris Young noted that their supply chain “starts to shine” during acceleration, directly contributing to profitability beyond what utilization or pricing alone can achieve.
Capacity expansion plans are not merely reactive but strategically sequenced to capture exponential growth, with AXT targeting $35 million per quarter InP capacity by end-2026 (implying ~$140 million annualized run rate), doubling again to $65–70 million per quarter by 2027–2028 (~$260–280 million annualized), and already repurposing brownfield sites and securing adjacent facilities to accelerate execution—this speed-to-capacity advantage, enabled by existing infrastructure and engineering expertise, allows AXT to respond faster than competitors who face longer greenfield build times, positioning the company to capture market share during the imminent inflection point in CPO and high-speed optical device adoption beginning in late 2027.
Despite near-term export permit volatility affecting GaAs and regional shipments, InP revenue recognition in Q2 is supported by $34 million of already-permitted or permit-exempt orders, with management expressing high confidence in achieving sequential revenue growth and Q2 being the largest InP quarter in company history; this near-term visibility, combined with improving gross margin trends (non-GAAP at 29.9% in Q1 and guided toward 30%+ in Q2), reflects a transition from loss to profitability driven by operating leverage, favorable product mix shift toward higher-margin InP, and incremental contributions from the raw material joint ventures—factors that suggest the market is underestimating the speed and durability of AXT’s path to sustained profitability.
AXT, Inc. is positioned to capitalize on a structural shift in the indium phosphide (InP) substrate market driven by accelerating AI infrastructure investment and the emergence of co-packaged optics (CPO), with management signaling that the substrate market could grow four to six times over the next three to five years, far exceeding near-term cyclical fluctuations and creating a multi-year demand tailwind that remains underappreciated by the market; this is reinforced by the company’s record backlog exceeding $100 million, which reflects not just transient demand but deeper customer visibility and long-term supply agreement discussions with tier-one laser manufacturers, optical transceiver makers, and even hyperscalers’ end customers, indicating a broadening and deepening of the customer base beyond traditional clients.
The company’s unique integrated supply chain strategy—including ownership of crystal growth furnaces, control over critical raw materials through subsidiaries like Jinmei refining high-purity indium, and in-house crucible production via BoYu—provides a durable competitive moat that is difficult for peers to replicate, especially as raw material constraints and export permitting complexities intensify; this vertical integration allows AXT to maintain margin stability and supply reliability during periods of geopolitical stress, a factor highlighted when Morris Young noted that their supply chain “starts to shine” during acceleration, directly contributing to profitability beyond what utilization or pricing alone can achieve.
Capacity expansion plans are not merely reactive but strategically sequenced to capture exponential growth, with AXT targeting $35 million per quarter InP capacity by end-2026 (implying ~$140 million annualized run rate), doubling again to $65–70 million per quarter by 2027–2028 (~$260–280 million annualized), and already repurposing brownfield sites and securing adjacent facilities to accelerate execution—this speed-to-capacity advantage, enabled by existing infrastructure and engineering expertise, allows AXT to respond faster than competitors who face longer greenfield build times, positioning the company to capture market share during the imminent inflection point in CPO and high-speed optical device adoption beginning in late 2027.
Despite near-term export permit volatility affecting GaAs and regional shipments, InP revenue recognition in Q2 is supported by $34 million of already-permitted or permit-exempt orders, with management expressing high confidence in achieving sequential revenue growth and Q2 being the largest InP quarter in company history; this near-term visibility, combined with improving gross margin trends (non-GAAP at 29.9% in Q1 and guided toward 30%+ in Q2), reflects a transition from loss to profitability driven by operating leverage, favorable product mix shift toward higher-margin InP, and incremental contributions from the raw material joint ventures—factors that suggest the market is underestimating the speed and durability of AXT’s path to sustained profitability.
AXT, Inc.’s growth narrative remains heavily contingent on the unpredictable timing and approval of export permits from Chinese authorities, a geopolitical risk that management repeatedly acknowledges as outside their control and a primary limiter on revenue recognition, particularly for gallium arsenide and certain InP shipments to the U.S. and other regions; despite strong demand signals, the company can only recognize revenue on orders with existing permits or those exempt from licensing, creating a persistent mismatch between backlog and billings, as evidenced by the need to highlight $34 million of “realizable” Q2 revenue—a figure that underscores how much of the $100 million+ backlog remains stranded due to permitting delays, making financial performance highly sensitive to regulatory whims rather than fundamental demand.
While management emphasizes long-term supply agreements and customer engagement with tier-one players and hyperscalers, there is no evidence of finalized, long-term contracts in the transcript, with discussions remaining qualitative and forward-looking (“we expect to come to resolution in the very near future”), suggesting that pricing power and demand visibility may be overstated; furthermore, the shift in InP wafer mix toward higher-value In-doped material (now ~40% of backlog at large diameters) and 6-inch development is still in early stages, meaning near-term revenue remains weighted toward legacy 3-inch and 4-inch applications that are more price-sensitive and face greater competition, limiting near-term margin expansion beyond current levels.
The capital-intensive nature of capacity expansion—requiring ~$35 million in CapEx for 2026 brownfield upgrades, ~$100 million for the 2027–2028 adjacent facility, and potentially $200–250 million for a future greenfield site—implies significant dilution risk or balance sheet strain, especially given that the recent $632.5 million raise, while substantial, must fund not only capacity but also R&D, working capital, and Tongmei-related initiatives, and with cumulative CapEx needs potentially exceeding $350 million over the next few years, the company may face pressure to seek additional financing before full capacity ramp, potentially undermining shareholder returns despite strong top-line growth.
Gross margin improvement, while real in Q1 (non-GAAP 29.9%), remains dependent on achieving and sustaining higher utilization and a favorable mix shift toward InP, yet management tempered expectations by stating that gross margins in the 30% range are a “reasonable” outside-world target and that targeting levels “beginning with a four” (i.e., 40%+) is “far out,” indicating that the market may be overestimating the speed and scale of margin expansion; furthermore, the benefits of the integrated supply chain (Jinmei, BoYu) are described as complementary and only fully realized during acceleration, implying that any slowdown in demand or capacity utilization could quickly erode these advantages, leaving the company vulnerable to cyclical downturns despite its structural positioning.
AXT, Inc.’s growth narrative remains heavily contingent on the unpredictable timing and approval of export permits from Chinese authorities, a geopolitical risk that management repeatedly acknowledges as outside their control and a primary limiter on revenue recognition, particularly for gallium arsenide and certain InP shipments to the U.S. and other regions; despite strong demand signals, the company can only recognize revenue on orders with existing permits or those exempt from licensing, creating a persistent mismatch between backlog and billings, as evidenced by the need to highlight $34 million of “realizable” Q2 revenue—a figure that underscores how much of the $100 million+ backlog remains stranded due to permitting delays, making financial performance highly sensitive to regulatory whims rather than fundamental demand.
While management emphasizes long-term supply agreements and customer engagement with tier-one players and hyperscalers, there is no evidence of finalized, long-term contracts in the transcript, with discussions remaining qualitative and forward-looking (“we expect to come to resolution in the very near future”), suggesting that pricing power and demand visibility may be overstated; furthermore, the shift in InP wafer mix toward higher-value In-doped material (now ~40% of backlog at large diameters) and 6-inch development is still in early stages, meaning near-term revenue remains weighted toward legacy 3-inch and 4-inch applications that are more price-sensitive and face greater competition, limiting near-term margin expansion beyond current levels.
The capital-intensive nature of capacity expansion—requiring ~$35 million in CapEx for 2026 brownfield upgrades, ~$100 million for the 2027–2028 adjacent facility, and potentially $200–250 million for a future greenfield site—implies significant dilution risk or balance sheet strain, especially given that the recent $632.5 million raise, while substantial, must fund not only capacity but also R&D, working capital, and Tongmei-related initiatives, and with cumulative CapEx needs potentially exceeding $350 million over the next few years, the company may face pressure to seek additional financing before full capacity ramp, potentially undermining shareholder returns despite strong top-line growth.
Gross margin improvement, while real in Q1 (non-GAAP 29.9%), remains dependent on achieving and sustaining higher utilization and a favorable mix shift toward InP, yet management tempered expectations by stating that gross margins in the 30% range are a “reasonable” outside-world target and that targeting levels “beginning with a four” (i.e., 40%+) is “far out,” indicating that the market may be overestimating the speed and scale of margin expansion; furthermore, the benefits of the integrated supply chain (Jinmei, BoYu) are described as complementary and only fully realized during acceleration, implying that any slowdown in demand or capacity utilization could quickly erode these advantages, leaving the company vulnerable to cyclical downturns despite its structural positioning.